Lilly, Novo dominance to continue as TD Cowen lifts 2030 GLP-1 sales forecast by 38%
TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030, indicating ...
Floor & Decor price target raised to $110 from $102 at TD Cowen
TD Cowen raised the firm’s price target on Floor & Decor to $110 from $102 and keeps a Hold rating on the shares. The firm ...